Geritrex Recalls Carb-O-Philic 40 Cream Due to CGMP Deviation
Geritrex Corp recalls specific lots of Carb-O-Philic 40% Cream due to poor container closure. Check your NDC and lot numbers for details.
Recall notice
CGMP Deviation: Poor container closure of the bulk storage container
Contact the company
What happened, in plain English
Geritrex Corporation is recalling Carb-O-Philic 40 Cream, 40%, in both 3 oz. and 7 oz. tubes. The recall addresses a Current Good Manufacturing Practice (CGMP) deviation involving poor container closure of the bulk storage container. This issue affects specific lots with expiration dates of August 2016. Read more at govinfonow.com/recall/44205-geritrex-corp-recalls-carb-o-philic-40-cream-40-a.
Source Summary by GovInfoNow · govinfonow.com/recall/44205-geritrex-corp-recalls-carb-o-philic-40-cream-40-a · Updated October 12, 2026 · FDA enforcement record: FDA #D-1238-2015
Cite this page
“Geritrex Recalls Carb-O-Philic 40 Cream Due to CGMP Deviation.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/44205-geritrex-corp-recalls-carb-o-philic-40-cream-40-a. Based on FDA recall #D-1238-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1238-2015%22&limit=1).
Why it’s dangerous
The hazard is described as a 'CGMP Deviation: Poor container closure of the bulk storage container.' The record does not explain what specific contamination, degradation, or safety risk results from this manufacturing issue.
Who’s affected
Individuals who have been prescribed Carb-O-Philic 40% Cream and possess tubes from the affected lots. The record does not specify which injuries or risks are associated with this specific CGMP deviation.
How to tell if you have this one
Look for Carb-O-Philic 40 Cream, 40%, Rx Only. Check for NDC 54162-640-03 (3 oz. tube) with Lot # 1502076 or NDC 54162-640-07 (7 oz. tube) with Lot # 1502077 or 1503030. All affected products have an expiration date of 08/16.
- Brand
Geritrex- Category
Drug
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 21 months after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Questions people ask
What is the specific health risk associated with this recall?
The record states there was a 'CGMP Deviation: Poor container closure' but does not describe the specific injury or health risk.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1238-2015 (June 5, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1238-2015 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.